Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

NCT04377945 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Business reasons

Conditions

Dyskinesias
Parkinson Disease

Interventions

DRUG: Part 1, JM-010 component Group A
DRUG: Part 1, JM-010 component Group B
DRUG: Part 1, JM-010 component Group C
DRUG: Part 1, Placebo Group
DRUG: Part 2, JM-010 combination Group A
DRUG: Part 2, JM-010 combination Group B
DRUG: Part 2, JM-010 component Group C
DRUG: Part 2, Placebo Group

Sponsor

Bukwang Pharmaceutical